Continuous theta burst stimulation for bipolar depression: A multicenter, double-blind randomized controlled study exploring treatment efficacy and predictive potential of kynurenine metabolites
Journal of Affective Disorders · 2024-09 · 361 · 693-701
DOI: 10.1016/j.jad.2024.06.078 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Affective Disorders, 2024-09. Verfasst von Annelies Dellink und 9 weiteren Autor:innen. Beteiligte Einrichtung: Scientific Initiative of Neuropsychiatric and Psychopharmacological Studies (SINAPS), University Psychiatric Centre Duffel, Duffel, Belgium; Collabor…. Hauptthemen laut MEDLINE: Bipolar Disorder, Kynurenine, Transcranial Magnetic Stimulation, Quinolinic Acid. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: The Hercules Foundation.
Themen: Depression
Abstract (Originalsprache)
BACKGROUND: While theta burst stimulation (TBS) shows promise in Major Depressive Disorder (MDD), its effectiveness in bipolar depression (BD-D) remains uncertain. Optimizing treatment parameters is crucial in the pursuit of rapid symptom relief. Moreover, aligning with personalized treatment strategies and increased interest in immunopsychiatry, biomarker-based stratification of patients most likely to benefit from TBS might improve remission rates. We investigated treatment effectiveness of continuous TBS (cTBS) compared to sham in BD-D, and assessed the capacity of plasma kynurenine pathway metabolites to predict treatment outcome. METHODS: Thirty-seven patients with BD-D underwent accelerated active or sham cTBS treatment in a multicenter, double-blind, randomized controlled trial. Depressive symptoms were measured with the 17-item Hamilton Depression Rating Scale (HDRS-17) before treatment (T0), 3-4 days posttreatment (T1) and 10-11 days posttreatment (T2). Plasma tryptophan, kynurenine, kynurenic acid and quinolinic acid concentrations were quantified with ELISA. Linear mixed models were used for statistical analyses. RESULTS: Although the total sample showed depressive symptom improvement, active cTBS did not demonstrate greater symptom alleviation compared to sham. However, higher baseline quinolinic acid significantly predicted symptom improvement in the active treatment group, not in sham-stimulated patients. LIMITATIONS: The modest sample size limited the power to detect significant differences with regard to treatment effect. Also, the follow-up period was 10-11 days, whereas similar studies usually follow up for at least one month. CONCLUSION: More research is required to optimize cTBS for BD-D and explore the involvement of quinolinic acid in treatment outcome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Scientific Initiative of Neuropsychiatric and Psychopharmacological Studies (SINAPS), University Psychiatric Centre Duffel, Duffel, Belgium; Collaborative Antwerp Psychiatric Research Institute (CAPRI), Faculty of Medic…
- Department of Psychiatry, Universitair Ziekenhuis Brussel, Brussels, Belgium; Neuroprotection and Neuromodulation Research Group (NEUR), Center for Neurosciences (C4N), Vrije Universiteit Brussel (VUB), Brussels, Belgiu…
- Sint-Maria Halle Hospital, Belgium.
- Department of Psychiatry, University Psychiatric Center KU Leuven, Leuven, Belgium.
- Neuroprotection and Neuromodulation Research Group (NEUR), Center for Neurosciences (C4N), Vrije Universiteit Brussel (VUB), Brussels, Belgium; Ghent Experimental Psychiatry (GHEP) Lab, Ghent University, Ghent, Belgium.
Förderung
- The Hercules Foundation
Zitieren
APA
Dellink, A., Hebbrecht, K., Zeeuws, D., Baeken, C., De Fré, G., Bervoets, C., De Witte, S., Sabbe, B., Morrens, M., & Coppens, V. (2024). Continuous theta burst stimulation for bipolar depression: A multicenter, double-blind randomized controlled study exploring treatment efficacy and predictive potential of kynurenine metabolites. Journal of Affective Disorders, 361, 693-701. https://doi.org/10.1016/j.jad.2024.06.078
Vancouver
Dellink A, Hebbrecht K, Zeeuws D, Baeken C, De Fré G, Bervoets C, et al. Continuous theta burst stimulation for bipolar depression: A multicenter, double-blind randomized controlled study exploring treatment efficacy and predictive potential of kynurenine metabolites. Journal of Affective Disorders. 2024;361:693-701. doi:10.1016/j.jad.2024.06.078
BibTeX
@article{Dellink2024,
author = {Dellink, Annelies and Hebbrecht, Kaat and Zeeuws, Dieter and Baeken, Chris and De Fré, Gerard and Bervoets, Chris and De Witte, Sara and Sabbe, Bernard and Morrens, Manuel and Coppens, Violette},
title = {Continuous theta burst stimulation for bipolar depression: A multicenter, double-blind randomized controlled study exploring treatment efficacy and predictive potential of kynurenine metabolites},
journal = {Journal of Affective Disorders},
year = {2024},
volume = {361},
pages = {693--701},
doi = {10.1016/j.jad.2024.06.078}
}
EUVIMED